Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. (Q37222191)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 June 2016
edit
Language Label Description Also known as
English
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer.
scientific article published on 29 June 2016

    Statements

    Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit